Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronic Simulect in Kidney Transplant
NCT00928811Phase 3Terminated
- Sponsor
- Drexel University
- Start
- May 2009
- Primary completion
- Apr 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of basiliximab in kidney transplant rejection, sponsored by Drexel University. Started May 2009; status: terminated.
02
Drugs
basiliximab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00928811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928811.